comparemela.com
  1. Home
  2. Live Updates
  3. Bluesky Immunotherapies Gmbh Ltd - Breaking News

Latest Breaking News On - Bluesky immunotherapies gmbh ltd - Page 1 : comparemela.com

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Thomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer straBluesky immunotherapies gmbhHealth care amp hospitalsStem scienceClinical trials amp medical discoveries

BlueSky Immunotherapies GmbH: Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.

Kostenloser wertpapierhandelThomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer stra

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Thomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer straBluesky immunotherapies gmbh

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.